Scientists have successfully used an inhibitor of the chemical 20-HETE to control the growth and spread of human glioblastomas and breast cancer in laboratory models

Columbia biomedical engineers design a new, biomaterials-based system that takes a soft approach to improving cell manufacturing and may bring new hope to cancer patients for T-cell therapy

There is a critical need to non-invasively and remotely manipulate cells at a distance, particularly for translational applications in animals and humans, researchers said

By closely mimicking the ventricular action of the heart, the pulsatile blood pump provides physiological advantages for perfusion, blood transfers, blood cellular profile studies, and more

New pan-cancer cell-free total nucleic acid (cfTNA) assay and FFPE-based tumor mutation load analysis assay, coupled with novel Ion AmpliSeq HD technology, extend industry-leading Oncomine menu and enable panel design customization

Combines EMR and NLP data to deliver the industry’s most comprehensive data set for cohort analysis and site selection

The new dye will help medical researchers track the progression of a wide array of diseases, such as cancer

According to research firm Market Research Future (Pune, India), the global biomarker test market will reach $16 billion by 2022

“It is only through robust, sustained, and predictable federal funding for research that we can continue to bring hope to the millions of people who are touched by cancer,” said AACR CEO

Experts endorse recommendations for blood transfusions that reduce blood use to improve patient safety and outcomes